Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Neoadjuvant Chemotherapy in Stage III Breast Cancer
NCT01907529Phase 3Unknown
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in breast cancer, sponsored by The Fourth Hospital of Hebei Medical University. Status: unknown.
02
Drugs
endostar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01907529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01907529.